» Articles » PMID: 34737790

Screening Hub Genes of Hepatocellular Carcinoma Based on Public Databases

Overview
Publisher Hindawi
Date 2021 Nov 5
PMID 34737790
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor recurrence and metastasis often occur in HCC patients after surgery, and the prognosis is not optimistic. Hence, searching effective biomarkers for prognosis of is of great importance. Firstly, HCC-related data was acquired from the TCGA and GEO databases. Based on GEO data, 256 differentially expressed genes (DEGs) were obtained firstly. Subsequently, to clarify function of DEGs, clusterProfiler package was used to conduct functional enrichment analyses on DEGs. Protein-protein interaction (PPI) network analysis screened 20 key genes. The key genes were filtered via GEPIA database, by which 11 hub genes (F9, CYP3A4, ASPM, AURKA, CDC20, CDCA5, NCAP, PRC1, PTTG1, TOP2A, and KIFC1) were screened out. Then, univariate Cox analysis was applied to construct a prognostic model, followed by a prediction performance validation. With the risk score calculated by the model and common clinical features, univariate and multivariate analyses were carried out to assess whether the prognostic model could be used independently for prognostic prediction. In conclusion, the current study screened HCC prognostic gene signature based on public databases.

Citing Articles

Bioinformatics combined with network pharmacology and experimental validation to identify key biomarkers of hepatocellular carcinoma and corresponding compounds in Radix Astragali and Pueraria Mirifica.

Li M, Liu B, Xian M, Wang S, Liu P Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39549064 DOI: 10.1007/s00210-024-03597-4.


Immunotherapy and drug sensitivity predictive roles of a novel prognostic model in hepatocellular carcinoma.

Gao X, Ren X, Wang F, Ren X, Liu M, Cui G Sci Rep. 2024; 14(1):9509.

PMID: 38664521 PMC: 11045740. DOI: 10.1038/s41598-024-59877-9.


Identification of Prognostic Biomarkers for Suppressing Tumorigenesis and Metastasis of Hepatocellular Carcinoma through Transcriptome Analysis.

Mishra D, Mishra A, Rai S, Vamanu E, Singh M Diagnostics (Basel). 2023; 13(5).

PMID: 36900109 PMC: 10001411. DOI: 10.3390/diagnostics13050965.


The clinical significance of integrin subunit alpha V in cancers: from small cell lung carcinoma to pan-cancer.

Tang Y, Li G, Li D, Tang D, Huang J, Feng H BMC Pulm Med. 2022; 22(1):300.

PMID: 35927660 PMC: 9354352. DOI: 10.1186/s12890-022-02095-8.

References
1.
Bashour A, Bloom G . 58K, a microtubule-binding Golgi protein, is a formiminotransferase cyclodeaminase. J Biol Chem. 1998; 273(31):19612-7. DOI: 10.1074/jbc.273.31.19612. View

2.
Chen J, Chen Z, Huang Z, Yu H, Li Y, Huang W . Formiminotransferase Cyclodeaminase Suppresses Hepatocellular Carcinoma by Modulating Cell Apoptosis, DNA Damage, and Phosphatidylinositol 3-Kinases (PI3K)/Akt Signaling Pathway. Med Sci Monit. 2019; 25:4474-4484. PMC: 6592141. DOI: 10.12659/MSM.916202. View

3.
Watanuki A, Ohwada S, Fukusato T, Makita F, Yamada T, Kikuchi A . Prognostic significance of DNA topoisomerase IIalpha expression in human hepatocellular carcinoma. . Anticancer Res. 2002; 22(2B):1113-9. View

4.
Shi M, Dai W, Jia R, Zhang Q, Wei J, Wang Y . APC-mediated degradation of PHD3 stabilizes HIF-1a and promotes tumorigenesis in hepatocellular carcinoma. Cancer Lett. 2020; 496:144-155. DOI: 10.1016/j.canlet.2020.10.011. View

5.
Tuo L, Xiang J, Pan X, Hu J, Tang H, Liang L . PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27 axis. J Exp Clin Cancer Res. 2019; 38(1):50. PMC: 6360696. DOI: 10.1186/s13046-019-1029-y. View